Derek Hainy

Derek Hainy

Healthcare Regulation Expert
Derek Hainy is a public policy expert specializing in healthcare regulation. He provides insightful analysis of the latest regulatory changes affecting healthcare providers. Focusing on compliance, Derek helps medical professionals navigate healthcare laws, requirements, and reforms. He also covers the future of healthcare data privacy regulations and the regulatory landscape for telehealth services. 
Can Malaysia Regulate Exorbitant Private Hospital Fees Successfully?
Public Policy Can Malaysia Regulate Exorbitant Private Hospital Fees Successfully?

Malaysia is grappling with the challenge of regulating the costs of private hospital services, as public discontent escalates over rising medical expenses. Despite health insurance being regulated by Bank Negara Malaysia, private hospital charges remain largely unchecked, except for doctors

Global Regulations Struggle to Keep Up with Rapid Digital Health Advances
Public Policy Global Regulations Struggle to Keep Up with Rapid Digital Health Advances

Digital health technologies are rapidly advancing, fundamentally transforming how healthcare is delivered and impacting public health on a global scale. Yet, as these technologies proliferate, regulatory frameworks struggle to keep pace, varying significantly across different regions, with the

How Can Healthcare Meet Data Regulations Amid Rising Cyber Threats?
Public Policy How Can Healthcare Meet Data Regulations Amid Rising Cyber Threats?

The healthcare sector is facing a growing dilemma: balancing stringent data regulations with the escalating threat of cyberattacks. As the field navigates this dual challenge, it becomes crucial to develop strategies that ensure compliance while safeguarding sensitive patient information. The

How is Private Health Insurance Regulated in the United States?
Public Policy How is Private Health Insurance Regulated in the United States?

The regulation of private health insurance in the United States is a complex and multifaceted system involving an intricate blend of state and federal laws. The interplay between these layers of regulation significantly defines the landscape of private health coverage, particularly emphasized by

Supreme Court Orders Regulation of India’s Allied Healthcare Sector
Public Policy Supreme Court Orders Regulation of India’s Allied Healthcare Sector

The allied healthcare sector in India has been burgeoning with institutions, but the quality has been inconsistent due to the lack of regulation. The Supreme Court of India has taken a significant step by issuing a mandate to regulate this sector comprehensively. This mandate includes the formation

WHO’s New Guide on AI Regulation Aims to Enhance Healthcare Safety
Public Policy WHO’s New Guide on AI Regulation Aims to Enhance Healthcare Safety

In a significant move designed to ensure the safety, effectiveness, and proper implementation of artificial intelligence (AI) technologies in healthcare, the World Health Organization (WHO) has released a comprehensive publication outlining key regulatory considerations. The document's primary

EU AI Act Revolutionizes Healthcare, Focusing on Safety and Fairness
Public Policy EU AI Act Revolutionizes Healthcare, Focusing on Safety and Fairness

The European Union's pioneering AI Act, poised to dramatically alter the landscape of healthcare and life sciences across Europe, shines a spotlight on the urgent need for compliance among companies involved in AI applications from production to clinical operations. As the regulation drives

How Will Illinois' New Health Insurance Reforms Impact Patients?
Public Policy How Will Illinois' New Health Insurance Reforms Impact Patients?

With the introduction of major new health insurance reforms in Illinois, patients are poised to experience significant changes in their access to and quality of health care services. The recently signed measures—House Bill 5395 and House Bill 2499—aim to correct some of the most contentious pra

Can the FDA Overcome Challenges in Postmarket Device Surveillance?
Public Policy Can the FDA Overcome Challenges in Postmarket Device Surveillance?

In an era marked by rapid advancements in medical technology, ensuring the safety and efficacy of medical devices remains paramount. The Food and Drug Administration (FDA) has been working diligently on developing a postmarket surveillance system, driven by a 2012 federal law aimed at reducing the

BIOSECURE Act: Modernizing U.S. Pharma and Reducing China Dependency
Public Policy BIOSECURE Act: Modernizing U.S. Pharma and Reducing China Dependency

The U.S. pharmaceutical sector faces a critical juncture. With a heavy reliance on Chinese manufacturing for generic drugs and active pharmaceutical ingredients (APIs), the industry finds itself vulnerable. The BIOSECURE Act aims to address these vulnerabilities by reducing or eliminating

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later